Women with cancer are not the only people who struggle to cope with intimacy-related issues as they pertain to health problems. Women who are experiencing chronic pain, decreased libido, and menopause are all examples of people who need a place to turn for information and clinical research statistics. These are all areas in which the Patty Brisben Foundation for Women’s Sexual Health sees a disparity in the amount of clinical research being undertaken today.
With these ideas in mind, the Patty Brisben Foundation for Women’s Sexual Health pledges to support the following clinical endeavors:
- Research that seeks to understand the nature of women’s sexuality and sexual health
- Research that seeks to understand how women develop and sustain relationships, obtain information about their bodies and manage the complex sexuality issues that arise when faced with chronic illness
- The Foundation aims to improve the response of healthcare providers to patients’ sexuality issues, particularly as they relate to the Patty Brisben Foundation’s Four Areas of Focus:
Vulvovaginal Pain Disorders
- An estimated six million women currently suffer from vulvodynia, a disorder defined as chronic vulvar pain without an identifiable cause.
- The average woman with pain during intercourse sees seven doctors before she receives a diagnosis.
Sexual Health Issues Related to Peri-Menopause and Menopause
- During menopause, mood swings, short-term memory loss, and difficulty thinking clearly are common complaints that can adversely affect women’s mental health and overall well-being.
Intimacy-Related Sexual Dysfunction After Cancer Treatments
- The Patty Brisben Foundation funded the largest study to date on young survivors of breast cancer. 95 percent indicated that cancer had adversely affected their sexuality.
Libido and Desire
- The Patty Brisben Foundation is funding a study at the University of Cincinnati’s College of Medicine to determine if birth control pills and other hormonal contraceptives negatively impact a woman’s sexual desire and whether any effects increase with higher level dosages.